Sponsor:
June Wu
Code:
NCT06833320
Conditions
Postoperative Chylothorax
Congenital Heart Disease
Open Heart Surgery
Chylothorax
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Not accepted
Interventions
Propranolol Hydrochloride
Placebo
Brief summary:
Conditions
Postoperative Chylothorax
Congenital Heart Disease
Open Heart Surgery
Chylothorax
Study ID
NCT06833320
Start date
Sep 9, 2025
Status verified date
Nov, 2026
Completion date
Jan 1, 2031
Anticipated
Primary completion date
Sep 30, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 18
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
placebo comparator: Placebo
active comparator: Propranolol hydrochloride
Interventions
Propranolol Hydrochloride
Placebo
Primary outcome measure
Central contacts
Locations
Columbia University Irving Medical Center/NewYork-Presbyterian
Recruiting
New York, New York, United States, 10032
Sponsor
June Wu
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by June Wu on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.